The role of prophylactic transfusion on the maternal and fetal outcomes in pregnant women with sickle cell disease: A systematic review and meta-analysis
Open Access
- 6 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (36) , e39475
Abstract
Background: In the present review, we aimed to synthesize evidence from studies on the safety and effectiveness of prophylactic blood transfusion in pregnant women with sickle cell disease. Material and methods: To gather relevant information, we conducted systematic electronic searches of databases such as SCOPUS, Medline via PubMed, Web of Science, and Cochrane Central Register of Controlled Trials. We included both retrospective and prospective studies that examined the impact of prophylactic blood transfusions during pregnancy. The collected data were analyzed using Review Manager, version 5.3. Results: The review included 15 cohort studies. The overall findings indicated a preference for the prophylactic blood transfusion group over the control group across several key parameters. Specifically, the prophylactic group demonstrated lower rates of maternal mortality (odds ratio [OR] = 0.33; 95% confidence interval [CI] = 0.10–1.13; P = .08), reduced incidence of vaso-occlusive painful events (OR = 0.31; 95% CI = 0.14–0.73; P = .007), fewer pulmonary complications (OR = 0.21; 95% CI = 0.08–0.53; P = .001), decreased perinatal mortality (OR = 0.35; 95% CI = 0.17–0.75; P = .03), and lower likelihood of preterm birth (OR = 0.67; 95% CI = 0.47–0.96; P = .02). Notably, statistically significant heterogeneities were observed in the pooled effect estimates. Conclusion: The present meta-analysis indicated that prophylactic blood transfusion in pregnant women with sickle cell disease may improve maternal and fetal outcomes. However, substantial variations in the methodology and transfusion protocols among the included studies limited the credibility of the current evidence supporting the routine clinical use of prophylactic transfusion for SCD during pregnancy.Keywords
This publication has 36 references indexed in Scilit:
- Maternal and perinatal outcomes in pregnant women with sickle cell disease: an updateHematology, Transfusion and Cell Therapy, 2021
- Role of prophylactic and therapeutic red blood cell exchange in pregnancy with sickle cell disease: Maternal and perinatal outcomesJournal of Clinical Apheresis, 2020
- Transfusion‐related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatoryAmerican Journal of Hematology, 2018
- Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusionsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2010
- Morbidity associated with sickle cell disease in pregnancyAmerican Journal of Obstetrics and Gynecology, 2008
- Third‐trimester erythrocytapheresis in pregnant patients with sickle cell diseaseInternational Journal of Gynecology & Obstetrics, 2006
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell diseaseJournal of Clinical Apheresis, 1991
- Management of sickle cell anemia and pregnancyJournal of Clinical Apheresis, 1991
- Use of partial exchange transfusion preoperatively in patients with sickle cell hemoglobinopathiesAmerican Journal of Obstetrics and Gynecology, 1978